Get the Stockscreener App
0.00
100.00%
-179.95
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Masimo Corp is a medical technology company. The company oepates in single segment namely Healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The company sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, and others.
See More
Previous Close:
$179.95
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$9.42B
Revenue:
$1.56B
Net Income/Loss:
$216.80M
P/E Ratio:
0.00
EPS:
1.458
Net Cash Flow:
$206.10M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$179.99
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
0.00 | 9.42B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
103.36 | 178.85B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
91.62 | 117.19B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
270.01 | 103.57B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.10 | 62.46B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.77 | 50.01B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-17-25 | Initiated | BofA Securities | Neutral |
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Apple Watch Ban In Masimo ITC Patent Case Hits High Court - Law360
Apple Fights Masimo Bid To Add $243M To $634M Patent Win - Law360
Masimo Patient Monitor Wins FDA Clearance - Orange County Business Journal
Masimo Receives FDA 510(k) Clearance for Root® with LiDCO® and the Masimo LiDCO Sensor to Provide Continuous Oxygen Delivery (DO₂) - Yahoo Finance
Masimo Receives CE Mark for AI-Powered smartSedLine™ Brain Function Monitor to Advance Anesthetic Management - Yahoo Finance
Masimo Heads For $10B Buyout After Winning Blood Oxygen Patent Case Against Apple - Stocktwits
Masimo Shareholder Action Reminder - TMX Newsfile
Masimo Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Masimo Corp (MASI): Pentwater Capital files 13G/A showing exit from common stock - Stock Titan
Apple Clears Major Legal Hurdle After US Trade Tribunal Shuts Down Masimo’s Latest Watch Ban Attempt - Stocktwits
Masimo, Staar Name New Leaders - Orange County Business Journal
Masimo Deadline Reminder - newsfilecorp.com
Inventor network analysis highlights opportunities and risks in Danaher's acquisition of Masimo - Lexology
Masimo Shareholder Alert - TMX Newsfile
New leaders named at Masimo, Danaher after deal closes - Modern Healthcare
Masimo names a new president - MassDevice
Masimo Shareholder Notice - TMX Newsfile
Masimo Appoints Tim Benner as President - Yahoo! Finance Canada
Masimo (MASI) Gains FDA Pediatric Clearance, But Is The Valuation Already Priced In? - Yahoo Finance
masi-20260103 - SEC.gov
Judge Upholds $643M Masimo Verdict - Orange County Business Journal
Masimo Corp Agencies, 2023 - opensecrets.org
The Denon AVR-X3800H. Masimo leans on flexible 8K home cinema - AD HOC NEWS
Masimo Ongoing Deadline Alert - newsfilecorp.com
Should Masimo’s Radius VSM Safety Recalls Prompt a Reassessment From Masimo (MASI) Investors? - Yahoo Finance
MSN Money - MSN
Full Fed. Circ. Won't Review Apple's ITC Loss Against Masimo - Law360
Apple loses its bid to get out of paying Masimo $634 million - MacTech.com
Apple loses bid to overturn $634 million Masimo patent verdict, new trial also denied - 9to5Mac
Denon AVR-X1800H by Masimo Corp.compact 8K receiver for Dolby Atmos living rooms - AD HOC NEWS
Masimo Retains $634 Million Patent Win Over Apple Watch Feature - Bloomberg Law News
Apple Can't Get Judge To Toss Masimo's $634M Patent Verdict - Law360
SIRI stock surges 5% after-hours on S&P MidCap 400 inclusion - MSN
Denon AVR-X2800H by Masimo Corp.mid-range receiver gets HEOS and 8K update - ad-hoc-news.de
Danaher-Masimo close caps med tech’s strongest first-half since 2022 - BioWorld News
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover - Sahm
Masimo Corp highlights patient monitoring portfolio as Nasdaq-listed medical technology player - Ad Hoc News
The Denon AVR-X2800H. A mid-range receiver quietly pushing Masimo’s Sound United audio strategy - ad-hoc-news.de
Masimo Corp focuses on patient monitoring innovation as investors assess long-term growth prospects - ad-hoc-news.de
Danaher slips as investors weigh soft diagnostics trends and Masimo integration risk - Quiver Quantitative
Masimo Radius T from Masimo Corp.wireless wearable for hospital telemetry - ad-hoc-news.de
California Judge Denies Masimo Board Effort to Toss Kiani Case - Bloomberg Law News
Denon AH-D5200 from Masimo Corp.closed-back wood headphones quietly anchor the premium hi-fi line - ad-hoc-news.de
Denon AVR-X3800H from Masimo Corp.9.4-channel receiver pushes home theaters into 8K and HEOS stre - ad-hoc-news.de
Denon Home 350 from Masimo Corp.big-room wireless speaker with serious multiroom chops - ad-hoc-news.de
Danaher Corp adjusts guidance after Masimo deal. Analysts highlight cautious upside for the stock - Ad Hoc News
Deals tracker: Select Medical Holdings acquisition moves forward - Modern Healthcare
Lobbying Update: $50,000 of MASIMO CORPORATION lobbying was just disclosed - Quiver Quantitative
Danaher (DHR) Completes $9.9B Acquisition of Masimo Corporation - Yahoo Finance
Denon AVC-X3900H from Masimo Corp.9.4 channels and 8K-ready home cinema hub - Ad-hoc-news.de
The Denon AVR-X3800H from Masimo Corp.9.4-channel cinema, HDMI 2.1 and HEOS streaming - Ad-hoc-news.de
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):